Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 22, 2010

Probactive and Vietnamese Organization to Combine Antibodies with Radioactive Compounds for Cancer

  • Probactive Biotech and Vietnamese organization Dalat Nuclear Research Institute are collaborating to develop cancer drugs that combine antitumor antibodies and radioactive compounds.

    Probactive Biotech says that it has combined medical-grade iodine-131 and yttrium-90 with antitumor antibodies, producing targeted anticancer activity.

    Parts of the R&D program will be completed at the Dalat Nuclear Research Institute. Clinical trials will be conducted in Vietnam under the regulatory guidelines of the Ministry of Health and also in compliance with FDA regulations.

     



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »